Clinical Trials Directory

Trials / Completed

CompletedNCT01843621

A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children

A Phase I/II, Open, Five-year, Clinical Follow-up Study of Thai Children Who Participated in Dengue-003 ("A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children") With Evaluation of a Booster Dose Given One Year After Primary DEN Vaccination Series

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
7 (actual)
Sponsor
U.S. Army Medical Research and Development Command · Federal
Sex
All
Age
6 Years – 9 Years
Healthy volunteers
Accepted

Summary

One year follow-up on immunogenicity and safety of a booster dose of DEN vaccine administered approx. 1 year following the second dose

Detailed description

The purpose of this study is to find out more about the two doses of dengue vaccine, over a five year period, that the children received in the Dengue-003 study and to study a third dose of dengue that will be given to the children * Do children still have dengue antibodies intended to provide protection against dengue infection one year after the two doses of vaccine given in study Dengue-003? * Were there any major medical problems that appeared as dengue-like symptoms during the one year after vaccinations? * Will a third dose of dengue help to further stimulate the part of the immune system intended to help protect against dengue infection? * Is a third dose as safe as the first two doses? * Are the local reactions to a third dose of the vaccine similar to what your child experienced after the first two doses?

Conditions

Interventions

TypeNameDescription
BIOLOGICALDEN vaccine F17The dengue booster vaccine was administered subcutaneously in the non-dominant arm (deltoid). The tetravalent, live attenuated DEN F17 vaccine was administered in this study. This pre-transfection formulation contained dengue virus types 1, 2, 3 and 4 (DEN-1, -2, -3 and -4).

Timeline

Start date
2005-02-01
Primary completion
2005-02-01
Completion
2009-02-01
First posted
2013-04-30
Last updated
2018-11-26
Results posted
2018-11-26

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01843621. Inclusion in this directory is not an endorsement.